WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate ...
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by the human papillomavirus (HPV), a viral infection that spreads ...
When it comes to men's health, prostate cancer tends to fly under the radar. The disease can go undetected for years, especially in the early stages when symptoms may not be noticeable. Prostate ...
Landmark trials have driven a shift from radical mastectomies to less invasive, breast-conserving surgeries. Non-invasive breast carcinomas, when detected early, have highly favorable survival and ...
Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results